Injective files SEC transfer agent registration for on-chain securities
Regulation & Gov ·
Injective submitted a transfer agent registration to the SEC on July 16, seeking a regulated pathway to issue and manage securities directly on its blockchain.
The filing targets a specific regulatory role: transfer agents are the entities the SEC authorizes to record securities ownership, process transfers, and maintain shareholder records. By registering in that capacity, Injective is positioning its infrastructure to handle those functions natively on-chain rather than through traditional intermediaries, a step framed as opening a compliant US route for issuing securities on the network, according to a post from Injective.
The move sits alongside a broader push by Injective to court institutional and regulatory attention. The chain is described in explainer coverage as a finance-first layer-1 built on the Cosmos SDK with Tendermint-based proof-of-stake consensus, capable of processing over 10,000 transactions per second, and designed to host derivatives markets, real-world assets, and stablecoin settlement. Its interoperability, spanning native IBC connections within Cosmos plus links to Ethereum, Solana, Polygon, Aptos, and Avalanche via protocols such as Wormhole, is presented as core to its ambition to serve as a cross-chain settlement hub for liquidity and derivatives.
The transfer agent filing follows other regulatory and market milestones tied to Injective, including its emergence as the first altcoin with CFTC-regulated futures listed on Bitnomial, a development noted as starting an ETF approval clock. Real-world-asset activity on the chain has also expanded, with Musicow tapping Injective to tokenize fractional music IP rights tied to a $200B market. Separately, Injective has been building out infrastructure for autonomous trading agents, including an MCP toolset giving AI agents 22 tools to trade perpetuals, bridge tokens, and query markets, and an agent platform using ERC-8004 identities with automatic fee payouts.
Two distinct sources are tracked covering the transfer agent filing itself, both describing the same July 16 submission and its aim of enabling regulated securities issuance on-chain. What remains unclear is the SEC's review timeline, whether the registration will be approved, and what specific securities products Injective or its partners intend to issue under the new structure once, or if, the registration is granted.